Cargando…
Distinct profiles of LRRK2 activation and Rab GTPase phosphorylation in clinical samples from different PD cohorts
Despite several advances in the field, pharmacodynamic outcome measures reflective of LRRK2 kinase activity in clinical biofluids remain urgently needed. A variety of targets and approaches have been utilized including assessments of LRRK2 itself (levels, phosphorylation), or its substrates (e.g. Ra...
Autores principales: | Petropoulou-Vathi, Lilian, Simitsi, Athina, Valkimadi, Politymi-Eleni, Kedariti, Maria, Dimitrakopoulos, Lampros, Koros, Christos, Papadimitriou, Dimitra, Papadimitriou, Alexandros, Stefanis, Leonidas, Alcalay, Roy N., Rideout, Hardy J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177829/ https://www.ncbi.nlm.nih.gov/pubmed/35676398 http://dx.doi.org/10.1038/s41531-022-00336-5 |
Ejemplares similares
-
Activation of FADD-Dependent Neuronal Death Pathways as a Predictor of Pathogenicity for LRRK2 Mutations
por: Melachroinou, Katerina, et al.
Publicado: (2016) -
The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson’s Disease
por: Polissidis, Alexia, et al.
Publicado: (2020) -
A motif within the armadillo repeat of Parkinson’s-linked LRRK2 interacts with FADD to hijack the extrinsic death pathway
por: Antoniou, Nasia, et al.
Publicado: (2018) -
LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson’s disease
por: Kedariti, Maria, et al.
Publicado: (2022) -
Rab GTPases as Physiological Substrates of LRRK2 Kinase
por: Seol, Wongi, et al.
Publicado: (2019)